CME vs MORN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

CME

37.7
AI Score
VS
MORN Wins

MORN

33.6
AI Score

Investment Advisor Scores

CME

38score
Recommendation
SELL

MORN

34score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric CME MORN Winner
Forward P/E 21.7865 16.2866 MORN
PEG Ratio 4.68 2.31 MORN
Revenue Growth 0.8% 9.6% MORN
Earnings Growth 2.5% 35.4% MORN
Tradestie Score 37.7/100 33.6/100 CME
Profit Margin 63.4% 16.4% CME
Beta 1.00 1.00 Tie
AI Recommendation SELL EXTENDED MORN

Relative Price Performance (Last 90 Days)

CME 1M: +8.1% · 3M: -4.9% MORN 1M: +28.9% · 3M: +24.6%

Current Technical Phase

CME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 64.7 · Price: $274.98

MORN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.3% over 20 days), RSI 72

RSI (14): 72.0 · Price: $215.97

Fundamentals Snapshot

Metric CME MORN
Market Cap
Forward P/E 21.3 15.5
Trailing P/E 22.6 20.7
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 1.0% 0.6%
Operating Margin 0.7% 0.2%
EPS 11.97 10.51
Dividend Yield 0.02% 0.01%

Frequently Asked Questions

Based on our detailed analysis, MORN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.